ImmunityBio, Inc.IBRXNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank92
3Y CAGR+0.9%
5Y CAGR+10.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+0.9%/yr
vs +41.0%/yr prior
5Y CAGR
+10.2%/yr
Recent deceleration
Acceleration
-40.2pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $360.75M | +0.5% |
| 2024 | $358.93M | -1.1% |
| 2023 | $362.87M | +3.2% |
| 2022 | $351.54M | +6.1% |
| 2021 | $331.21M | +49.5% |
| 2020 | $221.49M | +282.3% |
| 2019 | $57.94M | -34.8% |
| 2018 | $88.88M | -5.0% |
| 2017 | $93.60M | -22.6% |
| 2016 | $120.94M | - |